Other Knowledge Centres
Alzheimer's Disease
Arthritis
Asthma
Atopic Dermatitis
Cholesterol
Chronic Myeloid Leukemia
COPD
Contraception
Cystic Fibrosis
Diabetes
Gastrointestinal Stromal Tumours
Hepatitis
(HPV) & Cervical Cancer
Hypertension
Insomnia
Lysosomal Storage Disorders
Men's Health
Migraine
Niemann-Pick
Non-small Cell Lung Cancer
Ophthalmics
Opioids and Pain
Osteoarthritis (EULAR Webcast)
Parkinson's Disease
Post-MI Heart Failure
Prostate Cancer
Renal Cell Carcinoma
Renal Anaemia
Soft Tissue Sarcoma
Disease Topics
Allergy and Clinical Immunology
Anesthesiology
Angiology
Cardiology
Central Nervous System
Clinical Laboratory
Complementary and Alternative Medicine
Critical Care/Intensive Care
Dermatology
Diabetes and Endocrinology
Ear, Nose and Throat
Emergency Medicine
Eye Health and Disorders
Family Medicine
Gastroenterology
Gerontology/Geriatrics
Haematology
Hepatology
HIV/AIDS
Immunology
Infectious Diseases
Internal Medicine
Kidney and Urological Diseases
Medical Genetics
Men's Health, Andrology and Urology
Musculoskeletal Disorders
Neonatal/Perinatal Medicine
Neurological Disorders
Nutrition and Dietetics
Oncology
Orthopaedics
Paediatrics
Pain Management
Palliative Medicine
Plastic Surgery and Aesthetic Medicine
Podiatry
Preventive Medicine
Psychiatry/Mental Health
Radiology
Respiratory
Rheumatology
Sexual Health
Sleep Medicine
Sports Medicine
Surgery (General)
Thrombosis
Transplantation
Tropical Medicine
Vaccines
Women's Health and Obs/Gyn
Back to EPG Online
EPG Diabetes Knowledge Centre
Home
The Need For Insulin Analogues
Treatment Overview
Treatment Options
IDF 2005
Further Reading
Home
Home Page
Initiating Treatment
Screening
Oral
Insulin
Options
Dual Action
Short term action
Long term action
IDF Guidelines
Lifestyle Management
Self-Monitoring
Glucose Control Levels
Studies
Long-term clinical and cost outcomes
Attainment of Glycemic Goals
Insulin study in people with type 2 diabetes
Welcome to the
EPG Diabetes Knowledge Centre
a service to medicine sponsored
by
Novo Nordisk